All patients were confirmed to be positive for p16INK4A and HPV16 E7 in tumor by immunohistochemistry and detection of HPV16 E7 mRNA and HPV16 DNA with “HPV-detect”, respectively. Here, CDKN2A is linked to neoplasm.